Check Cap Ltd
Veridion Score
BETAHIGH CONF · 6/6 factorsComposite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.
- · Factor breakdown with raw signals
- · Day-over-day delta + driver
- · Factor coverage readout
- · Valuation · hype · market flow
- · Pro Chart event markers
- · Score history + alerts
Why is MBAI moving today?
Check-Cap Ltd is a clinical-stage medical diagnostics company engaged in the development of an ingestible imaging capsule that utilizes low-dose X-rays for the detection and imaging of colonic polyps and colorectal cancers, or CRC. The company is developing C-Scan, the first capsule-based system for preparation-free, colorectal cancer screening. Its scanning capsule will be swallowed and propelled by natural motility through the gastrointestinal tract and excreted naturally with no need for retrieval for data collection. The operations of the company are presently located in Israel, but plans to market products in the United States, Europe, Israel and Japan.
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
MBAI overview
Related filings and maps
Congress activity in MBAI
No receipt-qualified Congressional disclosure is present for MBAI in the cached public ledger.
MBAI contract awards, year to date.
Public federal awards linked to this ticker.
MBAI lobbying filings, year to date.
Registered lobbying filings matched to Check Cap Ltd.